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Abstract: Measurements of Cherenkov emission in tissue during radiation 
therapy are shown to enable estimation of hemoglobin oxygen saturation 
non-invasively, through spectral fitting of the spontaneous emissions from 
the treated tissue. Tissue oxygenation plays a critical role in the efficacy of 
radiation therapy to kill tumor tissue. Yet in-vivo measurement of this has 
remained elusive in routine use because of the complexity of oxygen 
measurement techniques. There is a spectrally broad emission of Cherenkov 
light that is induced during the time of irradiation, and as this travels 
through tissue from the point of the radiation deposition, the tissue 
absorption and scatter impart spectral changes. These changes can be 
quantified by diffuse spectral fitting of the signal. Thus Cherenkov emission 
spectroscopy is demonstrated for the first time quantitatively in vitro and 
qualitatively in vivo, and has potential for real-time online tracking of tissue 
oxygen during radiation therapy when fully characterized and developed. 
©2012 Optical Society of America 
OCIS codes: (170.1470) Blood or tissue constituent monitoring; (170.3660) Light propagation 
in tissues; (170.6510) Spectroscopy, tissue diagnostics; (170.6280) Spectroscopy, fluorescence 
and luminescence. 
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1. Introduction 
Recently it was demonstrated that Cherenkov emission is induced by MeV photons or 
electrons from a linear accelerator and detectable using a CMOS camera [1]. In particular, the 
blue-dominated spectral emission could excite an embedded fluorophore such as 
protoporphyrin IX which is known to be present at increased levels in tumors. The optical 
Cherenkov signal is induced when highly energetic charged particles travel through a 
dispersive medium like tissue. Based on this origin of contrast several reports have also 
shown the ability to image radioisotopes in vitro as well as in vivo [2–5]. Although optical 
Cherenkov emission is strongest in the blue, the broad band characteristics is well known with 
an intensity spectrum proportional to 3~ 1 λ , or the number of photons per wavelength is 
proportional to 2~ 1 λ  [6]. As this light propagates through tissue it will be affected by the 
oxygenated and deoxygenated hemoglobin as well as other chromophores. The difference in 
absorption between the hemoglobin chromophores is routinely used in NIR spectroscopy for 
tissue oxygenation assessments. 
Tissue oxygenation plays a critical role in the efficacy of radiation therapy to kill tumor 
tissue [7]. Inadequate oxygen supply in tumor tissue (i.e. hypoxic areas) may lead to treatment 
failure through insufficient DNA damage in the tumor [8], and several clinical and pre-
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clinical studies have shown that oxygenation monitoring is a prognostic factor in radiation 
therapy [8, 9]. Multi-center clinical studies have shown that pre-treatment tissue oxygen 
pressure (pO2) is predictive of outcome in head and neck cancers [10], and other studies have 
shown that the pO2 increases during the course of fractionated external beam radiation therapy 
[11], and that this change is correlated to effective local control. Optical hemoglobin 
spectroscopy has been used in-vivo, to show that oxygen hemoglobin saturation increases 
during fractionated radiation therapy in a rodent tumor model [12]. 
In this work, we show how oxygen saturation spectroscopy is achieved in-vivo and 
noninvasively, simply by measurement and spectral fitting of the endogenously emitted 
Cherenkov emission signal, as altered by absorption as it leaves the tissue or origin. A method 
is presented that relies on the spectral fitting of a theoretical light transport model to the 
Cherenkov emission spectrum. This study is the first presentation of this spectral signature, 
and will be followed by quantitative validation in further animal studies. By quantifying the 
absorption of the emitted photons coming from tissue chromophores, the hemoglobin oxygen 
saturation can be estimated. This is the first spectroscopic application of Cherenkov emission 
spectroscopy (CES) providing real-time physiological information about the tissue 
undergoing external beam radiation therapy. 
2. Materials and methods 
2.1 External beam radiation and experimental setup 
All experiments were performed with a linear accelerator (Varian Clinac 2100C, Varian 
Medical Systems, Palo Alto, USA). A circular beam shape with 30 mm diameter or a semi-
circular beam shape with 24 mm diameter was used. Electron beams were used in all 
experiments with an approximate dose rate of 4Gy/min. The setup is shown schematically in 
Fig. 1(a). The fiber-bundle was positioned at 90° with respect to the external beam direction 
in order to minimize the Cherenkov emission induced directly in the fiber material [13]. 
Measurements of Cherenkov spectra were all taken while the radiation beam was directly 
hitting the phantoms or tissues. 
2.2 Mathematical model of external beam induced Cherenkov emission 
Cherenkov emission is induced when electrons with a kinetic energy above 0.219 MeV 
propagate through a dispersive medium [14, 15]. The number of emitted Cherenkov photons, 
denoted ( ),N Eλ , within a spectral interval [ ],λ λ λ λ− ∆ + ∆  due to an electron with kinetic 
energy E  propagating a distance dx  is given by the Frank-Tamm formula [16], i.e. 
 ( )
( )2 2
2 1 1 1
, 1
137
dN E dx
E n
π
λ
λ λ λ λ β
   = − −  − ∆ + ∆  
 (1) 
In Eq. (1), n  is the refractive index of the medium, assumed to be 1.33 for water and 1.4 
for soft tissue, and ( )Eβ  is the velocity of the electron relative to the speed of light and its 
energy dependence is given by [15] 
 ( )
1
2 2
11
1
0.511
E
E
β
  
  
 = −  
  +    
 (2) 
The number of Cherenkov photons emitted within the spectral interval 400-700 nm is 
calculated using Eq. (1) and plotted in Fig. 1(b). 
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Fig. 1. Experimental setup. (a) a schematics showing the setup where electron beam irradiates 
from top of phantom. (b) the Frank-Tamm formula is plotted showing the number of photons 
generated per mm and electron for varying energy. (c) electron range as a function of energy. 
(d-f) electron beams at 6, 12 and 18 MeV irradiating a water tank. (g-i) electron beams 
irradiating a scattering solution of saline and intralipid. (j-l) electron beams irradiating a 
scattering phantom with added blood. (m) a schematic showing the optical point sources 
distributed throughout the electron beam. 
As the electron propagates through the medium its kinetic energy will dissipate through 
inelastic collisions and according to the continuous slowing down approximation [17] the 
energy decreases linearly with depth. Assuming that an electron travels on a straight path 
from the surface given by the z-direction, the kinetic energy can be approximated by Harder’s 
formula [17], i.e. 
 0 1 .
p
zE E
R
 
= −  
 
 (3) 
Here 0E (MeV) is the electron’s incident energy at the surface and pR (mm) is the 
practical range of the electrons here given by 
 04.612 3.074.pR E= × +  (4) 
Equation (4) is retrieved from a linear fit to several data sources i.e [15], [17]. and [18], 
specifying the most probable energy as a function of range. The data and linear fit is shown in 
Fig. 1(c). 
Since the photon yield, in Eq. (1), is dependent on the energy and the energy decreases 
with depth, the number of emitted Cherenkov photons will change dependent on electron 
propagation distance. The depth dependent Cherenkov photon yield is then given by inserting 
Eq. (3) in Eq. (2) and defining 
 ( )
( )
0 2 2
0
2 1 1 1
, , 1
137 ,
dN E z dx
E z n
π
λ
λ λ λ λ β
   = − −  − ∆ + ∆  
 (5) 
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where 
 ( )
1
2 2
0
0
1
, 1 .
1 1
0.511 p
E z
E z
R
β
  
  
  
= −     − +    
    
 (6) 
The energy (and depth) dependence of the Cherenkov emission is demonstrated in the 
photographs in Fig. 1(d)-(f) where a water tank was irradiated from the top by 6, 12 and 18 
MeV-electron beams. 
During external beam radiation therapy, Cherenkov emission is generated in tissue hence 
the optical photons are subject to strong scattering and absorption. The effect of optical 
scattering on the Cherenkov emission is seen in Fig. 1(g)-(i) while the color-change seen in 
Fig. 1(j)-(l) indicates the presence of a spectrally dependent absorber, in this case 0.2% 
porcine blood added to the phantom. In this study we assume the simplest approach and adopt 
the Green’s solution to the diffusion equation in order to describe the photon migration from 
the point of Cherenkov generation to the fiber bundle where the light is collected. However, 
as has been discussed above the Cherenkov emission is induced throughout the extent of the 
electron beam which is defined laterally by the beam shape and transversally by the electron 
range. Thus, absorption spectra of hemoglobin change the Cherenkov spectra, however the 
exact shape of the spectral distortion varies with beam profile and distance to the detecting 
fiber, as well as the expected variation with hemoglobin concentration and oxygenation. 
To model this effect, Eq. (5) defines the number of photons emitted at a specific depth. In 
order to implement this in a forward numerical model, multiple point sources (~27000) are 
positioned within the coordinates that defines the beam, seen schematically in Fig. 1(m). The 
point source strength, or power, is given by Eq. (5), i.e. point sources placed deeper into the 
medium irradiate slightly weaker. At the detector position, the contributions from all the point 
sources are added. The detected intensity at one wavelength can then be evaluated by 
 ( ) ( ) ( )0 eff
1
, ,
exp
4
M
i
i i
N E zhcI C R
DR
λ
λ µ
λ π=
= −∑  (7) 
Where ( )´ 13 'sD µ
−
=  and eff a Dµ µ=  is the wavelength-dependent diffusion coefficient 
and effective attenuation coefficient respectively. The constant C  accounts for dose rate as 
well as conversion between fluence rate and detector intensity. The summation is performed 
for M sources and the distance between each point source and the detector is given by iR , 
also shown schematically in Fig. 1(m). 
In order to retrieve a simulated Cherenkov emission spectrum Eq. (7) is evaluated for 
several wavelengths. For a given wavelength of interest, the waveband in Eq. (5) was chosen 
to be 0.5λ ± nm. 
2.3 Spectral fitting to retrieve chromophore concentrations 
The forward model presented above was used to extract the total hemoglobin concentration 
and hemoglobin oxygen saturation by a fitting procedure. The measured spectra and the 
calculated spectra were mean-normalized and compared within an iterative non-linear least 
squares method using Matlab 7.10.0 (The MathWorks Inc., Natick, Massachusetts, USA). 
Reduced scattering parameters were held constant within the fitting process and the 
wavelength dependent scattering was given by 
 '( ) b
s
Aµ λ λ −=  (8) 
#158358 - $15.00 USD Received 21 Nov 2011; revised 9 Jan 2012; accepted 10 Jan 2012; published 16 Feb 2012
(C) 2012 OSA 27 February 2012 / Vol. 20,  No. 5 / OPTICS EXPRESS  5137
  
where A  is the scatter amplitude, and b is the scatter power. Scatter amplitude and power for 
the intralipid solutions were calculated from [19] while the mouse optical scattering 
parameters were compiled from [20]. The absorption coefficient was defined by 
 
( )
2 22 2
( ) ( ) 1 ( ) ( )a tot HbO Hb w H OcHb SO SO Cµ λ ε λ ε λ µ λ = × + − + 
 (9) 
where totcHb  is the total hemoglobin concentration, is the oxygen saturation while 2HbOε  and 
Hbε  is the extinction coefficient for oxy- and deoxy-hemoglobin respectively at wavelength λ 
[21]. wC  is the water fraction, and 2H Oµ  is the absorption coefficient of pure water at 
wavelength λ [22]. 
In each iteration totcHb  and 2SO were updated before evaluating Eq. (7), and fitting for 
SO2 in Eq. (9) based upon the full spectrum of wavelengths measured, fitted simultaneously. 
In the phantom experiments the method was calibrated using a scattering phantom with no 
absorber while fitting for wC  only. This parameter was then fixed for the subsequent added 
blood experiments and the deoxygenation experiments. In the in vivo experiments calibration 
was performed using a euthanized animal assuming 0% oxygenation and 70% water fraction 
in the tissue. 
Commonly oxygenation of tissue is estimated by the partial pressure of oxygen, pO2, 
rather than SO2. The relationship between pO2 and SO2 is non-linear and described by the 
well known Hill saturation curve. While it is more informative to have direct measurement of 
pO2, it is largely recognized that direct measurement of this is challenging, due to the 
microscopic heterogeneity of pO2 change with distance from capillaries. Bulk tissue pO2 is 
thought to vary at least monotonically with bulk SO2 when measured in tissue volumes 
greater than a millimeter cubed, although related non-linearly by the Hill curve. In this work, 
the tissue pO2 was not directly measured although it is known that tissue pO2 and SO2 are 
both near zero within minutes of animal euthanasia, and normal tissue hemoglobin SO2 values 
can be in the range of 50-70% saturated. 
2.4 Phantom preparation 
The scattering liquid phantoms used in the experiments were made of phosphate buffered 
saline solution (D-PBS, Mediatech Inc, Manassas, VA), 0.2% v/v Intralipid© (Fresenius 
Kabi, Uppsala, Sweden) and porcine whole blood. Concentrations of 0.2% blood were used in 
most phantoms to mimic the expected concentration in murine skin. Prior to the experiments 
the hemoglobin concentration was measured using a hemoglobin meter (Hb 201 + , Hemocue, 
Ängelholm, Sweden). The oxygenation reference instrument was an ischemia monitoring 
system (Spectros T-stat, Spectros, Portola Valley, CA). Yeast was added in order to alter the 
oxygenation of the sample. 
2.5 Animal handling 
Four Balb/c mice were subject to external beam irradiation. Hair was removed by shaving the 
flanks of the animals. The mice were anesthetized with a ketamine/xylazine mixture 
administered intraperitoneally in a ratio of 90:10 mg/kg. Measurements were performed 
before and 30 min after the mice were euthanized through cervical dislocation. 
2.6 Spectrometer setup and data processing 
The spectrometer setup was governed by a spectrograph (Acton Insight, Princeton 
Instruments, Acton, USA) connected to a front illuminated CCD (Pixis 400F, Princeton 
Instruments, Acton, USA). The CCD was cooled to −70°C and the grating used in all 
experiments was 300 lines/mm. A 13 m long fiber bundle (Zlight, Latvia), composed of six 
400 µm diameter silica fibers, collected the light at the phantom and guided the photons to the 
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spectrometer. The fiber bundle tip was positioned in contact with phantom boundary at the top 
surface of the liquid in the center of the beam. All spectra were acquired with an integration 
time of 60 seconds. Each spectrum was subject to background subtraction, normalization with 
integration time and binning by averaging four neighboring spectral bins. In all experiments 
the Cherenkov emission induced in the fiber was acquired before each experiment, and 
subtracted before data analysis. 
2.7 Camera setup and image processing 
Images were acquired with a CMOS camera Nikon D90 (Nikon, Tokyo, Japan) equipped with 
a standard zoom lens Sigma EX 18-50/2.8 Macro HSM (Sigma Corporation, Kawasaki, 
Japan). The integration time for all images was 30 seconds. Images were processed by 
subtraction of a background image that was acquired in the same light conditions as when the 
beam irradiation was executed. 
3. Results 
3.1 Optical phantom experiments of hemoglobin concentration 
Phantoms, made of phosphate buffered saline solution (PBS), Intralipid© and porcine whole 
blood, were irradiated using a circular shaped electron beam at 18 MeV. The concentration of 
whole blood was changed and the spectra seen in Fig. 2(a) were obtained using the fiber-
coupled spectrometer during beam irradiation. By fitting the forward model to each spectrum 
the total hemoglobin concentration was assessed and is shown in Fig. 2(b). 
 
Fig. 2. Cherenkov emission spectroscopy of hemoglobin concentration. (a) Cherenkov 
emission spectra from phantom solutions with varying concentrations of porcine blood, 
indicated in the legend. (b) fitted values for the total hemoglobin concentration are offset 
against the true values. The inset shows the retrieved oxygenation values. 
The absolute values for the measured hemoglobin concentrations are within 25% of the 
true concentrations. The inset in Fig. 2(b) shows the oxygen saturation, which on average is 
93 +/− 4%. This value is in close agreement with the reference level of 92% that was acquired 
from the phantom using the ischemia monitoring system, see Materials and methods section. 
In Fig. 2(a) it is seen that the predominant change in the spectrum as a function of blood 
concentration occurs at wavelengths shorter than approximately 630 nm. 
3.2 Optical phantom experiments of oxygen saturation 
In order to investigate whether this technique is able to detect changes in tissue oxygenation, 
baking yeast was mixed into the scattering phantom containing blood. Measurements were 
acquired during beam irradiation before and approximately 30 minutes after adding the yeast. 
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Fig. 3. Cherenkov emission spectroscopy of tissue oxygenation. (a) spectra from a well-
oxygenated and a de-oxygenated scattering phantom solution are shown. The photos in (b) and 
(c) depict the color-change in the well- and de-oxygenated phantoms respectively. 
The spectra are seen in Fig. 3(a). A change in hemoglobin oxygen saturation will change 
the spectral intensity and a shift towards blue wavelengths is expected. This is seen in the 
photographs from the oxygenated phantom in Fig. 3(b) and the de-oxygenated phantom in 
Fig. 3(c). By fitting the forward model to the two spectra, the retrieved tissue oxygenation 
was 96% in the well-oxygenated case and 5% in the de-oxygenated case. From previous 
experiments the ability to deoxygenate a solution with yeast has been confirmed multiple 
times, and is a standard way to induce nearly 0% oxygen saturation in the phantom. 
3.3 In vivo experiments of tissue oxygenation 
In order to demonstrate the method in-vivo, four healthy Balb/c mice were subject to external 
beam radiation on the hind flank. An electron beam at 18 MeV, shaped like a half-circle, 
irradiated the flank of the animal, see Fig. 4(a). Irradiation was performed before and after 
sacrifice, rendering one spectrum from oxygenated tissue and one spectrum from 
deoxygenated tissue. 
 
Fig. 4. Cherenkov emission spectroscopy of tissue oxygenation in vivo. (a) mouse positioned 
in the target region with the beam profile delineated in red. (b) typical spectra from a mouse 
pre and post euthanasia. (c) the results from the fitting procedure for both total hemoglobin 
concentration (left y-axis) and oxygen saturation (right y-axis). The mean of four animals is 
shown and the error bars indicate the standard deviation of this small population. 
As with the phantom experiments the optical fiber was placed in the center of the beam. 
Typical spectra are seen in Fig. 4(b) and the results from the fitting procedure are stated in 
Fig. 4(c). As expected, after sacrifice, both the total hemoglobin concentration and 
consequently the oxygenation decrease. The differences in spectral shapes between the 
spectra from phantom experiments see Fig. 3(a), and in vivo experiments in Fig. 4(b) could be 
attributed to several factors. First, the scattering is most likely higher in the animal tissue than 
in the phantom solution making light from longer distances less likely to be detected. 
Secondly, the phantom geometry is large compared to the animal size allowing light to 
propagate throughout a larger volume. Thirdly, there might be other absorbers such as 
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melanin in the skin that perturb the spectral shapes. The in vivo results presented here are 
retrieved by calibrating the fitting procedure to a euthanized animal with assumed water 
content prior to the data evaluation. The SO2 values were 31% +/− 5% and 0% +/− 1% for 
normal respiration and after death, respectively. The hemoglobin values were 9 +/− 2 
microMolar and 6 +/− 2 microMolar in the same two conditions. Clearly the hemoglobin 
values were slightly lower than might be expected and the SO2 during anesthesia might be 
lower than expected, although anesthesia with ketamine is known to reduce these values in 
vivo. Validation with external measurements was not available, however the changes 
expected before and after euthanasia were as expected here. 
4. Discussion 
The results presented in this work indicate that quantitative spectral analysis of Cherenkov 
light is possible for emission generated by high-energy external beam radiation. The phantom 
studies show that it is feasible to track changes of both total hemoglobin concentration and 
hemoglobin oxygen saturation. The range of concentrations of hemoglobin and intralipid 
where not chosen to be exhaustive here, but rather chosen to mimic the scattering and 
hemoglobin values expected in mouse skin. The in vivo study further demonstrates the 
applicability where a clear change between pre- and post- euthanasia of the mice was 
quantified using the method described here. 
However, diffuse optical spectroscopy is non-unique meaning that several solutions exist 
to the inverse problem that satisfies the minimization criterion. This is a predicament arising 
from the fundamental property that light is diffusely scattered in tissue. Throughout this work 
the scattering properties of the medium under study, i.e. scattering amplitude and scattering 
power, have not been allowed to vary. In order to retrieve quantitative numbers for both 
chromophores and scattering properties, the spectral region needs to be optimized. A spectral 
interval at shorter wavelengths, e.g. between 480 and 650, seems to allow fitting of both 
chromophore concentrations and scattering parameters [12]. On the other hand shorter 
wavelengths make the method more sensitive to changes at shallow depths. In this work the 
fiber is placed in the beam since minimal Cherenkov emission was induced in the fiber if the 
angle between the beam and the fiber was 90°. However this setup makes the method mostly 
sensitive to changes in the tissue surface. In order to provide a more volumetric measure of 
the tissue oxygenation, more fibers are needed which could be easily added. The 
spectroscopic evaluation presented herein would in that case expand to a tomographic 
approach, see for example [23, 24]. Currently the optimal detector placement relative to the 
beam as well as optimal spectral interval to perform the data analysis is being investigated. 
The in-vivo results retrieved from the mice, pre- and post-sacrifice, indicate low 
hemoglobin oxygen saturation. Normal mouse skin is thought to be fairly well oxygenated, 
with published estimates near 75% [20]. However, the mice were anesthetized with 
ketamine/xylazine, which suppresses blood flow as well as tissue oxygenation. It has been 
reported that anesthesia using ketamine/xyalzine results in a drop of about 50% of the pO2 in 
a mouse leg muscle [25]. According to the oxygen dissociation curve a drop in pO2 of 50% 
corresponds to a decrease in hemoglobin oxygen saturation from 75% to around 30% [26]. 
Hence, the lower oxygen saturation retrieved in-vivo is quite reasonable. Validation of the 
SO2 values and hemoglobin concentration was not possible at the time of this experiment, as 
specialized instrumentation would be required to do this, however the values observed are 
within plausible ranges of what could be expected in mouse skin tissue. Certainly the tissue 
phantom data was indicative of reasonable values for nearly fully oxygenated solutions and 
nearly fully deoxygenated solutions. 
A low oxygen level in tumor tissue is a well-known prognostic marker for treatment 
failure of cancer and great efforts are dedicated to monitor and target these regions. PET 
imaging based on hypoxic markers [27, 28] can be used elegantly to reveal regions with 
oxygen deficiency using exogenous probes administered to the patient, but has had limited 
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clinical acceptance mostly due to cost. Cherenkov emission spectroscopy, as presented herein, 
will likely not be used for diagnosing hypoxic regions, unless within a few centimeters from 
the surface. However, the potential of the current method lies in treatment monitoring where 
changes in tissue oxygenation are of ample interest and are more accessible. The major benfit 
from Cherenkov light spectroscopy is the fact that the signal is inherently produced in all 
tissues being irradiated and requires no injectable contrast. However clearly the limitations are 
related to the penetration of the signal out of the volume being treated, or access by fiber 
optics to the region. Future work pursuing the idea of real-time evaluation of tissue 
oxygenation is warranted, and validation in tumor experiments with changes in tissue oxygen 
levels during fractionated therapy is planned based on this endogenous optical signal. 
5. Conclusions 
The demonstrated CES methodology provides the ability for quantitative analysis of 
hemoglobin concentration and oxygen saturation during external beam radiation therapy, as 
verified by tissue phantoms. The method utilizes the intrinsically generated Cherenkov 
radiation that is passively emitted from all tissue during radiation therapy. Preliminary in vivo 
testing has demonstrated that the values seen are plausible, and changes between living and 
dead tissue are as should be expected. This method has potential for tissue oxygenation 
monitoring during the course of standard fractionated radiation therapy treatments, thereby 
providing an easily implemented prognostic biomarker of the treatment efficacy. Further work 
must be done to quantitatively verify the estimation in vivo, using external correlates of tissue 
SO2 and hemoglobin concentration, and this work is ongoing. 
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